Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A Net Assets
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A net assets. Based on the latest financial reports, Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (301290) has net assets worth CN¥2.23 Billion CNY (≈ $325.86 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.47 Billion ≈ $360.76 Million USD) and total liabilities (CN¥238.50 Million ≈ $34.90 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Jiangsu Canopus Wisdom Medical Technolog net asset momentum to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥2.23 Billion |
| % of Total Assets | 90.33% |
| Annual Growth Rate | 22.94% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 41.91 |
Net Assets of Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (2020–2024)
Net assets of Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A from 2020 to 2024. This chart illustrates how Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A's net assets have evolved over time, based on quarterly financial data. See 301290 net asset quality index to measure how much of total assets are equity-financed.
Annual Net Assets for Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (2020–2024)
The table below shows the annual net assets of Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A from 2020 to 2024. For live market cap and overall valuation, see 301290 company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥2.25 Billion ≈ $329.77 Million |
+0.33% |
| 2023-12-31 | CN¥2.25 Billion ≈ $328.69 Million |
+1.93% |
| 2022-12-31 | CN¥2.20 Billion ≈ $322.48 Million |
+100.81% |
| 2021-12-31 | CN¥1.10 Billion ≈ $160.59 Million |
+11.26% |
| 2020-12-31 | CN¥986.37 Million ≈ $144.34 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 164.1% over the analyzed period, indicating profitable operations and earnings retention.
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A Net Assets Breakdown (December 2024)
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A net assets breakdown by equity component as of December 2024.
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥430.62 Million | 19.17% |
| Other Components | CN¥1.82 Billion | 80.83% |
| Total Equity | CN¥2.25 Billion | 100.00% |
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A Competitors by Market Cap
The table below lists competitors of Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hanwha Corp Preferred
KO:00088K
|
$372.64 Million |
|
Natural Gas Services Group Inc
NYSE:NGS
|
$372.77 Million |
|
Polyplex (Thailand) Public Company Limited
BK:PTL
|
$373.09 Million |
|
OceanPact Serviços Marítimos S.A
SA:OPCT3
|
$373.17 Million |
|
LB Foster Company
NASDAQ:FSTR
|
$372.61 Million |
|
Shandong Polymer Biochemicals Co Ltd
SHE:002476
|
$372.55 Million |
|
Simulations Plus Inc
NASDAQ:SLP
|
$372.54 Million |
|
I.C.C. International Public Company Limited
BK:ICC
|
$372.47 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,238,716,686 to 2,246,597,317, a change of 7,880,631 (0.4%).
- Net income of 97,424,753 contributed positively to equity growth.
- Dividend payments of 59,590,351 reduced retained earnings.
- Other factors decreased equity by 29,953,771.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥97.42 Million | +4.34% |
| Dividends Paid | CN¥59.59 Million | -2.65% |
| Other Changes | CN¥-29.95 Million | -1.33% |
| Total Change | CN¥- | 0.35% |
Book Value vs Market Value Analysis
This analysis compares Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.13x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.96x to 1.13x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | CN¥12.99 | CN¥25.42 | x |
| 2021-12-31 | CN¥14.46 | CN¥25.42 | x |
| 2022-12-31 | CN¥21.87 | CN¥25.42 | x |
| 2023-12-31 | CN¥22.35 | CN¥25.42 | x |
| 2024-12-31 | CN¥22.43 | CN¥25.42 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.34%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 22.37%
- • Asset Turnover: 0.18x
- • Equity Multiplier: 1.10x
- Recent ROE (4.34%) is below the historical average (6.34%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 8.17% | 21.29% | 0.33x | 1.17x | CN¥-17.89 Million |
| 2021 | 10.15% | 24.69% | 0.36x | 1.15x | CN¥1.64 Million |
| 2022 | 4.68% | 23.19% | 0.19x | 1.09x | CN¥-116.62 Million |
| 2023 | 4.34% | 22.42% | 0.18x | 1.07x | CN¥-126.65 Million |
| 2024 | 4.34% | 22.37% | 0.18x | 1.10x | CN¥-127.23 Million |
Industry Comparison
This section compares Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,751,772,335
- Average return on equity (ROE) among peers: 26.05%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (301290) | CN¥2.23 Billion | 8.17% | 0.11x | $372.62 Million |
| Shanghai Kehua Bio-Engineering Co Ltd (002022) | $1.27 Billion | 23.03% | 0.13x | $386.87 Million |
| Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) | $143.67 Million | 40.91% | 1.23x | $4.16 Billion |
| Double Medical Technology Inc (002901) | $3.69 Billion | 16.27% | 0.34x | $2.52 Billion |
| Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) | $6.77 Billion | 62.15% | 0.36x | $491.32 Million |
| Lepu Medical Tech Beijing (300003) | $115.51 Million | 55.06% | 0.54x | $3.37 Billion |
| INKON Life Technology Co Ltd (300143) | $2.07 Billion | 2.43% | 0.27x | $821.42 Million |
| Edan Instruments Inc (300206) | $1.22 Billion | 8.49% | 0.19x | $1.01 Billion |
| Guangdong Biolight Meditech Co Ltd (300246) | $46.53 Million | 22.70% | 0.68x | $503.27 Million |
| Beijing Leadman Biochemistry Co Ltd (300289) | $1.09 Billion | 11.74% | 0.48x | $475.25 Million |
| Sinocare Inc (300298) | $1.11 Billion | 17.76% | 0.09x | $1.54 Billion |
About Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A
Jiangsu Canopus Wisdom Medical Technology Co.,Ltd. engages in the research, development, manufacture, and sale of surgical medical devices and spare parts in China. It offers orthopedic traction frames, surgical lamps, hospital system integration solutions, electric gynecological examination tables, obstetrics and gynecology examination tables, electric operating tables, multi-functional intellig… Read more